Advertisement

Topics

Omega Pharma NV Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175

01:42 EDT 8 Oct 2018 | BioPortfolio Reports

Omega Pharma NV Strategy, SWOT and Corporate Finance Report


Summary


Omega Pharma NV Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.


Key Highlights


Omega Pharma NV Omega or 'the company', is a subsidiary of Perrigo Company plc, is engaged in the development, marketing and sales of overthecounter OTC pharmaceutical products. It also offers pain relief products, eye care products, sleep aid and antisnoring products, slimming products, and home diagnostics. The company primarily operates in Europe. Omega is headquartered in Nazareth, Belgium.


Scope


Detailed information on Omega Pharma NV required for business and competitor intelligence needs

A study of the major internal and external factors affecting Omega Pharma NV in the form of a SWOT analysis

An indepth view of the business model of Omega Pharma NV including a breakdown and examination of key business segments

Intelligence on Omega Pharma NV's mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Omega Pharma NV, such as business expansion, restructuring, and contract wins

Large number of easytograsp charts and graphs that present important data and key trends


Reasons to buy


Gain understanding of Omega Pharma NV and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Omega Pharma NV as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Omega Pharma NV's business structure, strategy and prospects.

Original Article: Omega Pharma NV Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175

NEXT ARTICLE

More From BioPortfolio on "Omega Pharma NV Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Pain Disorder
Pain is a feeling (sharp or dull) triggered in the nervous system which can be transient or constant. Pain can be specific to one area of the body eg back, abdomen or chest or more general all over the body eg muscles ache from the flu. Without pain ...

Sleep Disorders
Sleep disorders disrupt sleep during the night, or cause sleepiness during the day, caused by physiological or psychological factors. The common ones include snoring and sleep apnea, insomnia, parasomnias, sleep paralysis, restless legs syndrome, circa...